23/02/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

23/02/2025

Feb 23, 2025, 01:14 | Blog
Michael Kühn: Grateful for the invitation to return to MSKCC to discuss menin inhibition
Michael Kühn, Chief of Acute Leukemia Service at University Medical Center Mainz, shared a post…
Feb 23, 2025, 00:59 | Blog
Amy Nolan: Delighted to present Karen Slattery with the "Translational Research Award"
Amy Nolan, Director of Clinical Affairs at the Irish Cancer Society, posted on LinkedIn: "Delighted…
Feb 23, 2025, 00:54 | Blog
Florian Lordick: Honoured to be appointed as a visiting professor at the Charles University Prague
Florian Lordick, Professor of Medicine at the University of Leipzig, posted on LinkedIn: "I consider…
Feb 23, 2025, 00:51 | Blog
Douglas Flora: Start by Believing in the Good Intentions of Others
Douglas Flora, Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, shared a post…
Feb 23, 2025, 00:48 | Blog
Luis E Raez: Raising funding and awareness for lung cancer for GO2 Foundation
Luis E Raez, Medical Director Memorial Cancer Institute & Co-Director MCI/FAU Florida Cancer Center of…
Feb 23, 2025, 00:45 | Blog
Hesham ElGhazaly: Cairo Call to Action for Advancing Equity and Innovation in Women’s Cancer Care
Hesham ElGhazaly, Professor of Clinical Oncology at Ain Shams University and the Founder and CEO…
Feb 23, 2025, 00:42 | Blog
UICC welcomes three new organisations as members
Union for International Cancer Control (UICC) posted on LinkedIn: "We’re proud to welcome three organisations…
Feb 23, 2025, 00:38 | Blog
David R. Spigel: Breaking down barriers to make clinical trials more accessible for people facing cancer
David R. Spigel, Chief Scientific Officer at Sarah Cannon Research Institute, posted on LinkedIn: "Last…
Feb 23, 2025, 00:31 | Blog
Idah Phiri: Collaboration and networking drive real change!
Idah Phiri, Communications and Administration Manager at Zambian Cancer Society, posted on LinkedIn: "I am…
Feb 23, 2025, 00:14 | Insight
FDA Authorizes ImmunityBio to Provide Recombinant BCG as Alternative to TICE BCG Shortage for Bladder Cancer
On February 19, ImmunityBio, Inc. announced that the U.S. Food and Drug Administration (FDA) has…
All: 60 Posts: 51 - 60
Special Coverage